The Chamber of Regulation of the Medicines Market (CMED) releases, Monday (31), a new price of drugs sold in pharmacies and pharmacies. A. Lee nº 10,742, 2003.
However, this does not mean that there will be an automatic increase in the prices of practicing, but the definition of the permitted roof of the Registration. Determining the price of each product kept for sale, respecting its strategies in the wake of the established legal roof and competition – CE shades, distributors and retailers.
For the definition of new values, the CMED Council of Ministers have taken into account the last 12 months inflation, expanded National Consumer Price Index (IPCA), drug productivity and inflation that is not captured by inflation, powerful rate and market competition.
For example, in 2024, the annual regestation of the Drug Shada price is 4.5%, which is equal to the previous period of inflation index. List of maximum prices that can be charged by products It is available Site National Health Surveillance Agency (Anvisa).
According to Anvisa, The law provides for the annual price sealing adjustment to protect users from abusive growth, Confirm access to drugs and maintain population purchasing power. At the same time, the calculation established by the law tries to compensate for any risks of the CE shadow due to inflation and production costs, allowing a continuation of drugs.
If the consumer finds manipulations, it is possible Platform Consumer.Gov.BR. It is also possible to send a complaint directly to the CMED by Form is available on the Anvisa page.
Cmed is accompanied by the Ministry of Health, Home, Justice and Public Safety, Agriculture, and Development, Industry, Trade and Services. National Health Surveillance Agency has the performance of the Executive Secretariat, which provides technical assistance to decisions.
